It is reported that these failures are due to both the mislabeling of products and contamination from pesticides, bacteria, and processing chemicals.
This development comes at a disruptive time for UK cannabis regulations, as the drug has only recently been moved to a schedule 2 classification under the 2001 Misuse of Drugs Regulations act, allowing clinicians to prescribe it by the fall.
A member of the United States House of Representatives has submitted a bill to Congress which, if passed, would allow legal cannabis users to become federal employees.
Experts say that Canadian parents use unregulated cannabinoids for seizure control in children with neurologic conditions like epilepsy, and clinical trials are needed to inform doctors and parents on prescribing.
Failing to comply with the standards in place puts a cannabis company at risk of litigation and jeopardizes business contracts with other downstream cannabis operators.
Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.
AC Braddock, CEO of Eden Labs join us to discuss the role of cannabis extraction science and how extraction scientists are creating great cannabis products.